 DALLAS, Jan. 14, 2021 PRNewswire -- Lantern Pharma Nasdaq: LTRN, a clinical-stage biopharma company using its proprietary RADR artificial intelligence A.I. platform to transform cancer drug development and identify patients who will benefit from its targeted oncology... 